CIK: 0001420995 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 15, 2023
Total Value ($000): $49 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BRK/A | BERKSHIRE HATHAWAY INC DEL | 76 | $36 | 73.4% | $330761.80 | +35.7% | CL A | 084670108 |
| — | VIGIL NEUROSCIENCE INC | 192,973 | $2 | 5.0% | $0.01 | — | COM | 92673K108 |
| IRON | DISC MEDICINE INC | 110,488 | $2 | 4.5% | $49.79 | 0.0% | COM | 254604101 |
| TDG | TRANSDIGM GROUP INC | 3,103 | $2 | 4.0% | $503.62 | 0.0% | COM | 893641100 |
| — | RAPT THERAPEUTICS INC | 73,383 | $1 | 3.0% | $20.49 | — | COM | 75382E109 |
| CFLT | CONFLUENT INC | 65,191 | $1 | 3.0% | $23.17 | 0.0% | CLASS A COM | 20717M103 |
| XLO | XILIO THERAPEUTICS INC | 249,635 | $1 | 1.4% | $2.41 | 0.0% | COM | 98422T100 |
| — | VOR BIOPHARMA INC | 91,910 | $1 | 1.3% | $43.10 | — | COM | 929033108 |
| TNYA | TENAYA THERAPEUTICS INC | 291,828 | $1 | 1.2% | $21.49 | -88.6% | COM | 87990A106 |
| — | SURROZEN INC | 718,950 | $0 | 0.9% | $7.08 | — | COM | 86889P109 |
| — | AEROVATE THERAPEUTICS INC | 13,190 | $0 | 0.8% | $0.03 | — | COM | 008064107 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 1,100 | $0 | 0.7% | $220.20 | +34.9% | CL B NEW | 084670702 |
| AMPL | AMPLITUDE INC | 18,944 | $0 | 0.5% | $54.38 | -74.0% | COM CL A | 03213A104 |
| — | EVELO BIOSCIENCES INC | 113,850 | $0 | 0.4% | $12.09 | — | COM | 299734103 |
| SRZNW | SURROZEN INC | 33,333 | $0 | 0.0% | $1.14 | — | *W EXP 08/01/2 | 86889P117 |